Literature DB >> 23519076

PINK1 protects against cell death induced by mitochondrial depolarization, by phosphorylating Bcl-xL and impairing its pro-apoptotic cleavage.

G Arena1, V Gelmetti, L Torosantucci, D Vignone, G Lamorte, P De Rosa, E Cilia, E A Jonas, E M Valente.   

Abstract

Mutations in the PINK1 gene are a frequent cause of autosomal recessive Parkinson's disease (PD). PINK1 encodes a mitochondrial kinase with neuroprotective activity, implicated in maintaining mitochondrial homeostasis and function. In concurrence with Parkin, PINK1 regulates mitochondrial trafficking and degradation of damaged mitochondria through mitophagy. Moreover, PINK1 can activate autophagy by interacting with the pro-autophagic protein Beclin-1. Here, we report that, upon mitochondrial depolarization, PINK1 interacts with and phosphorylates Bcl-xL, an anti-apoptotic protein also known to inhibit autophagy through its binding to Beclin-1. PINK1-Bcl-xL interaction does not interfere either with Beclin-1 release from Bcl-xL or the mitophagy pathway; rather it protects against cell death by hindering the pro-apoptotic cleavage of Bcl-xL. Our data provide a functional link between PINK1, Bcl-xL and apoptosis, suggesting a novel mechanism through which PINK1 regulates cell survival. This pathway could be relevant for the pathogenesis of PD as well as other diseases including cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23519076      PMCID: PMC3679455          DOI: 10.1038/cdd.2013.19

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  43 in total

1.  Partial sensitization of human bladder cancer cells to a gene-therapeutic adenovirus carrying REIC/Dkk-3 by downregulation of BRPK/PINK1.

Authors:  Yu Jin; Hitoshi Murata; Masakiyo Sakaguchi; Ken Kataoka; Masami Watanabe; Yasutomo Nasu; Hiromi Kumon; Nam-Ho Huh
Journal:  Oncol Rep       Date:  2011-11-10       Impact factor: 3.906

2.  Identification of the major phosphorylation site in Bcl-xL induced by microtubule inhibitors and analysis of its functional significance.

Authors:  Meenakshi Upreti; Elena N Galitovskaya; Rong Chu; Alan J Tackett; David T Terrano; Susana Granell; Timothy C Chambers
Journal:  J Biol Chem       Date:  2008-10-30       Impact factor: 5.157

3.  Characterization of vinblastine-induced Bcl-xL and Bcl-2 phosphorylation: evidence for a novel protein kinase and a coordinated phosphorylation/dephosphorylation cycle associated with apoptosis induction.

Authors:  Lihua Du; Christopher S Lyle; Timothy C Chambers
Journal:  Oncogene       Date:  2005-01-06       Impact factor: 9.867

4.  Inhibition of bcl-x(l) phosphorylation by tea polyphenols or epigallocatechin-3-gallate is associated with prostate cancer cell apoptosis.

Authors:  Aslamuzzaman Kazi; David M Smith; Qing Zhong; Q Ping Dou
Journal:  Mol Pharmacol       Date:  2002-10       Impact factor: 4.436

Review 5.  Parkinson's disease: a genetic perspective.

Authors:  Andrea C Belin; Marie Westerlund
Journal:  FEBS J       Date:  2008-02-12       Impact factor: 5.542

6.  The Beclin 1 interactome.

Authors:  Congcong He; Beth Levine
Journal:  Curr Opin Cell Biol       Date:  2010-01-22       Impact factor: 8.382

7.  Bcl-xL is phosphorylated in malignant cells following microtubule disruption.

Authors:  M S Poruchynsky; E E Wang; C M Rudin; M V Blagosklonny; T Fojo
Journal:  Cancer Res       Date:  1998-08-01       Impact factor: 12.701

8.  Kinase-inactivated ULK proteins inhibit autophagy via their conserved C-terminal domains using an Atg13-independent mechanism.

Authors:  Edmond Y W Chan; Andrea Longatti; Nicole C McKnight; Sharon A Tooze
Journal:  Mol Cell Biol       Date:  2008-10-20       Impact factor: 4.272

9.  Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1.

Authors:  M Chiara Maiuri; Gaëtane Le Toumelin; Alfredo Criollo; Jean-Christophe Rain; Fabien Gautier; Philippe Juin; Ezgi Tasdemir; Gérard Pierron; Kostoula Troulinaki; Nektarios Tavernarakis; John A Hickman; Olivier Geneste; Guido Kroemer
Journal:  EMBO J       Date:  2007-04-19       Impact factor: 11.598

10.  Late onset sporadic Parkinson's disease caused by PINK1 mutations: clinical and functional study.

Authors:  Vania Gelmetti; Alessandro Ferraris; Livia Brusa; Francesca Romano; Federica Lombardi; Chiara Barzaghi; Paolo Stanzione; Barbara Garavaglia; Bruno Dallapiccola; Enza Maria Valente
Journal:  Mov Disord       Date:  2008-04-30       Impact factor: 10.338

View more
  56 in total

1.  A neo-substrate that amplifies catalytic activity of parkinson's-disease-related kinase PINK1.

Authors:  Nicholas T Hertz; Amandine Berthet; Martin L Sos; Kurt S Thorn; Al L Burlingame; Ken Nakamura; Kevan M Shokat
Journal:  Cell       Date:  2013-08-15       Impact factor: 41.582

2.  Midbrain dopamine neurons in Parkinson's disease exhibit a dysregulated miRNA and target-gene network.

Authors:  Christine E Briggs; Yulei Wang; Benjamin Kong; Tsung-Ung W Woo; Lakshmanan K Iyer; Kai C Sonntag
Journal:  Brain Res       Date:  2015-06-03       Impact factor: 3.252

3.  Akt Phosphorylates NQO1 and Triggers its Degradation, Abolishing Its Antioxidative Activities in Parkinson's Disease.

Authors:  Shilin Luo; Seong Su Kang; Zhi-Hao Wang; Xia Liu; Julia X Day; Zhiping Wu; Junmin Peng; Daxiong Xiang; Wolfdieter Springer; Keqiang Ye
Journal:  J Neurosci       Date:  2019-07-29       Impact factor: 6.167

4.  Autophagy, apoptosis, and mitochondria: molecular integration and physiological relevance in skeletal muscle.

Authors:  Darin Bloemberg; Joe Quadrilatero
Journal:  Am J Physiol Cell Physiol       Date:  2019-04-24       Impact factor: 4.249

5.  Chemical inhibition of FBXO7 reduces inflammation and confers neuroprotection by stabilizing the mitochondrial kinase PINK1.

Authors:  Yuan Liu; Travis B Lear; Manish Verma; Kent Zq Wang; P Anthony Otero; Alison C McKelvey; Sarah R Dunn; Erin Steer; Nicholas W Bateman; Christine Wu; Yu Jiang; Nathaniel M Weathington; Mauricio Rojas; Charleen T Chu; Bill B Chen; Rama K Mallampalli
Journal:  JCI Insight       Date:  2020-06-04

6.  Lugrandoside attenuates LPS-induced acute respiratory distress syndrome by anti-inflammation and anti-apoptosis in mice.

Authors:  Chengbao Li; Ying Huang; Xueya Yao; Baoji Hu; Suzhen Wu; Guannan Chen; Xin Lv; Fubo Tian
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

7.  Thyroid hormone: a resurgent treatment for an emergent concern.

Authors:  Mason T Breitzig; Matthew D Alleyn; Richard F Lockey; Narasaiah Kolliputi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-09-27       Impact factor: 5.464

8.  Pink1 attenuates propofol-induced apoptosis and oxidative stress in developing neurons.

Authors:  Chao Liang; Fang Du; Jing Cang; Zhanggang Xue
Journal:  J Anesth       Date:  2017-11-10       Impact factor: 2.078

9.  PINK1 and BECN1 relocalize at mitochondria-associated membranes during mitophagy and promote ER-mitochondria tethering and autophagosome formation.

Authors:  Vania Gelmetti; Priscilla De Rosa; Liliana Torosantucci; Elettra Sara Marini; Alessandra Romagnoli; Martina Di Rienzo; Giuseppe Arena; Domenico Vignone; Gian Maria Fimia; Enza Maria Valente
Journal:  Autophagy       Date:  2017-02-17       Impact factor: 16.016

Review 10.  Dysfunction of autophagy as the pathological mechanism of motor neuron disease based on a patient-specific disease model.

Authors:  Dan-Jing Yang; Liang Zhu; Jie Ren; Rong-Jie Ma; Hongwen Zhu; Jun Xu
Journal:  Neurosci Bull       Date:  2015-07-28       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.